MARKET

MXCT

MXCT

Maxcyte
NASDAQ
0.8080
0.0000
0.00%
After Hours: 0.8493 +0.0413 +5.11% 19:41 02/06 EST
OPEN
0.8118
PREV CLOSE
0.8080
HIGH
0.8606
LOW
0.7754
VOLUME
1.75M
TURNOVER
--
52 WEEK HIGH
4.670
52 WEEK LOW
0.7473
MARKET CAP
86.19M
P/E (TTM)
-1.8799
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at MXCT last week (0126-0130)?
Weekly Report · 6d ago
Weekly Report: what happened at MXCT last week (0119-0123)?
Weekly Report · 01/26 09:16
Weekly Report: what happened at MXCT last week (0112-0116)?
Weekly Report · 01/19 09:18
MaxCyte Expects Core Revenue of Up to $29.6 Million for 2025
Reuters · 01/12 21:46
MaxCyte Reports Q4 Revenue Around $6.7M Vs $9.3M Est, Full-Year Revenue Near $30M Vs $35.41M Est
Benzinga · 01/12 13:18
MaxCyte sees Q4 core revenue between $6.6M and $6.7M
Seeking Alpha · 01/12 13:16
MaxCyte sees Q4 core revenue $6.6M-$6.7M, consensus $9.3M
TipRanks · 01/12 13:15
*MaxCyte Sees FY25 Core Rev $29.5M - $29.6M >MXCT
Dow Jones · 01/12 13:11
More
About MXCT
MaxCyte, Inc. is a commercial cell engineering company. The Company is focused on providing enabling platform technologies to advance the discovery, development and commercialization of cell therapeutics, including cell and gene therapies, and to support cell-based research and development. It has developed and commercialized its proprietary Flow Electroporation technology, which is used by biopharmaceutical companies in the complex engineering of a variety of cells. Its ExPERT platform is based on its Flow Electroporation technology, which has been designed to address this rapidly expanding cell therapy market and can be utilized across the continuum of the cell therapy sector, from discovery and development through commercialization of cell-based medicines. The ExPERT family of products includes four instruments, which are known as the ATx, STx, GTx and VLx, as well as a portfolio of proprietary related disposables and consumables.

Webull offers MaxCyte Inc stock information, including NASDAQ: MXCT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MXCT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MXCT stock methods without spending real money on the virtual paper trading platform.